Evaluation of the safety and efficacy of the vaccine PB-116 in the control of porcine pleuropneumonia caused by Actinobacillus pleuropneumoniae

×

Error message

  • Notice: Trying to access array offset on value of type null in bootstrap_pager() (line 53 of /var/www/biosafety.be/sites/all/themes/bootstrap/templates/system/pager.func.php).
  • Notice: Trying to access array offset on value of type null in bootstrap_pager() (line 95 of /var/www/biosafety.be/sites/all/themes/bootstrap/templates/system/pager.func.php).
Study title: 
Evaluation of the safety and efficacy of the vaccine PB-116 in the control of porcine pleuropneumonia caused by Actinobacillus pleuropneumoniae
EU record number: 
B/BE/11/V3
Company / Sponsor: 
Laboratorios Hipra S.A.
Treated organism: 
pigs
Indication category: 
Active immunisation of fattening pigs for the prevention of the mortality, clinical signs and pulmonary lesions of the respiratory processes produced by Actinobacillus pleuropneumoniae
Genetic modification: 
no new genes but deletion of a segment of gene A from which depends the haemolytic activity of the pathogen
Method of transfer of nucleic acid of interest: 
Actinobacillus pleuropneumoniae strain HP-3179
Route of administration: 
intramuscular
Locations in Belgium: 
To be defined
Nr of subjects: 
2400 pigs but about 1200 in Belgium
Foreseen duration: 
to be defined
Type of procedure: 
Deliberate release only

Information related to the decision procedure